TITLE

Don't Hold Your Breath for a Block Takeout

AUTHOR(S)
Roberts, Ricardo
PUB. DATE
September 2000
SOURCE
Mergers & Acquisitions Report;09/11/2000, Vol. 13 Issue 36, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that Block Drug Company's stocks has been surging as the market anticipates a takeout. How Lee Pharmaceuticals President Ronald Lee viewed Block; What the company can offer; Stocks of Block; Potential acquirors for Block.
ACCESSION #
3605311

 

Related Articles

  • Is Block Drug Really on the Block? Roberts, Ricardo // Mergers & Acquisitions Report;06/19/2000, Vol. 13 Issue 25, p1 

    Reports that Block Drug Co. has retained the services of Goldman Sachs to explore strategic alternatives on sale and merger. Impact of its decision to retain the services of Goldman Sachs to its stock price; Forecast on revenue from its sales.

  • Just itching for sales. Sloan, P. // Advertising Age;5/18/1992, Vol. 63 Issue 20, p60 

    Reports that Block Drug Co. has overhauled pricing, packaging, and advertising strategy for Tegrin medicated shampoo in an effort to stay afloat in the shampoo market. Restaging follows several years of market share declines; New price-orientated campaign; Media spending; Comments.

  • Soap it up.  // Crain's New York Business;11/27/95, Vol. 11 Issue 48, p50 

    Reports on an announcement made by Block Drug Co., to buy the Lava soap brand from Procter & Gamble Inc., as in November 1995.

  • Jeff Meltzer posts Phazyme for Grey.  // SHOOT;06/07/96, Vol. 37 Issue 23, p57 

    Reports on the particulars of the advertisement created for Block Drug Co./Phazyme Infant Drops. Advertising Agency; Post production; Music; Storyline.

  • FIVE OF THE FINEST.  // njbiz;4/7/2003, Vol. 16 Issue 14, p2 

    Presents information on the top pharmaceutical performers on the Standard & Poor stock index in the U.S. based on the 'BusinessWeek' Top 50 list in 2003. Average net income growth of Johnson & Johnson; Factors considered in selecting the companies; Top three companies in the list.

  • Egis gains on profit expectations.  // Budapest Business Journal;2/4/2002, Vol. 10 Issue 9, p23 

    Reports the gain of the shares of Egis Rt, the second-largest pharmaceutical producer in Hungary.

  • Drug stocks offer both growth and stability.  // Dow Theory Forecasts;3/11/2002, Vol. 58 Issue 10, p1 

    Reports on the predicted growth of drug company stocks in the United States in 2002. Indicators to the start of the trend; Companies which are forecast to have accelerated growth.

  • Drug stocks: Expensive but worth every penny. Hill, Roger B. // Medical Economics;02/24/97, Vol. 74 Issue 4, p147 

    Recommends the stocks of select drug companies for investment purposes. Includes Merck; Bristol-Myers Squibb; British drugmaker Zeneca; Japanese pharmaceutical firms Eisai Pharmatechnology and Sankyo; Advice on how to identify auspicious companies.

  • Stock market briefcase.  // Business News New Jersey;11/30/98, Vol. 11 Issue 43, p15 

    Highlights news developments related to the stock performance of various pharmaceutical firms in New Jersey as of November 30, 1998. Decrease in the share price of pharmaceutical firm Johnson & Johnson; Decline in the share price of Tutogen Medical; Third quarter loss of Cytogen.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics